Whereas CCRL1 controlled intratumor T cell accumulation and activation in a murine mammary cancer cell line [57], SLFN13 was described as an immune-related biomarker that might predict tumor recurrence in lung cancer after curative resection [58]. This evidence concerns the gene SLFN13 and lung cancer.